pyridoxine has been researched along with Neurodegenerative Diseases in 4 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " An orally bioavailable GCP II inhibitor, 2-(3-mercaptopropyl) pentanedioic acid (2-MPPA), was administered daily at a dose of 30 mg/kg starting from the onset of pyridoxine injections." | 1.40 | Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats. ( Callizot, N; Potter, MC; Slusher, BS; Wozniak, KM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Potter, MC | 1 |
| Wozniak, KM | 1 |
| Callizot, N | 1 |
| Slusher, BS | 1 |
| Perry, TA | 1 |
| Weerasuriya, A | 1 |
| Mouton, PR | 1 |
| Holloway, HW | 1 |
| Greig, NH | 1 |
| Chung, JY | 1 |
| Choi, JH | 1 |
| Hwang, CY | 1 |
| Youn, HY | 1 |
| Diaz-Arrastia, R | 1 |
1 review available for pyridoxine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Homocysteine and neurologic disease.
Topics: Brain Diseases; Epilepsy; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Neurodegenerative | 2000 |
3 other studies available for pyridoxine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats.
Topics: Animals; Behavior, Animal; Female; Glutamate Carboxypeptidase II; Glutarates; Motor Activity; Neurod | 2014 |
Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy.
Topics: Animals; Cell Count; Cell Size; Disease Models, Animal; Disease Progression; Electrophysiology; Gang | 2004 |
Pyridoxine induced neuropathy by subcutaneous administration in dogs.
Topics: Animals; Body Weight; Disease Models, Animal; Dogs; Electrophysiology; Neurodegenerative Diseases; P | 2008 |